Cargando…
Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation
Background: Percutaneous left atrial appendage occlusion (LAAO) therapy using the WATCHMAN system has been introduced to prevent thrombosis and minimize the use of anticoagulants in patients with non-valvular atrial fibrillation. Given the high risk of bleeding and stroke in elderly patients, these...
Autores principales: | Fukuda, Nobuyuki, Imamura, Teruhiko, Tanaka, Shuhei, Kataoka, Naoya, Ushijima, Ryuichi, Ueno, Hiroshi, Kinugawa, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531715/ https://www.ncbi.nlm.nih.gov/pubmed/37762964 http://dx.doi.org/10.3390/jcm12186024 |
Ejemplares similares
-
Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan
por: Ueno, Hiroshi, et al.
Publicado: (2022) -
Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
por: Fukuda, Nobuyuki, et al.
Publicado: (2022) -
Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure
por: Tanaka, Shuhei, et al.
Publicado: (2021) -
Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure
por: Koi, Takahisa, et al.
Publicado: (2021) -
Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation
por: Lee, Oh-Hyun, et al.
Publicado: (2021)